CBIO
NASDAQ · Biotechnology
Crescent Biopharma Inc
$16.61
+0.36 (+2.22%)
Open$16.34
Previous Close$16.25
Day High$16.66
Day Low$16.01
52W High$27.41
52W Low$8.72
Volume—
Avg Volume425.8K
Market Cap628.10M
P/E Ratio—
EPS$-7.41
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+66.5% upside
Current
$16.61
$16.61
Target
$27.66
$27.66
$15.31
$27.66 avg
$30.74
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 39.31M | 57.99M | 51.60M |
| Net Income | -565,248,358 | 180.8K | 210.8K |
| Profit Margin | -1,438.1% | 0.3% | 0.4% |
| EBITDA | -552,946,728 | 390.2K | 358.0K |
| Free Cash Flow | — | 84.1K | 101.4K |
| Rev Growth | +413.7% | +8.6% | +24.1% |
| Debt/Equity | — | 0.52 | 0.47 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |